Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patientsMandeep Bajaj, Swangjit Suraamornkul, Paul Piper, et al.
Diabetes|May 27, 2003
Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetesMandeep Bajaj, Swangjit Suraamornkul, Thongchai Pratipanawatr, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 15, 2002
Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjectsThongchai Pratipanawatr, Wilailak Pratipanawatr, Clifford Rosen, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 6, 2004
Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetesSangeeta R Kashyap, Renata Belfort, Rachele Berria, et al.
The Journal of Biological Chemistry|December 16, 2004
Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscleDawn K Richardson, Sangeeta Kashyap, Mandeep Bajaj, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 18, 2020
<i>miR-30a</i> targets gene networks that promote browning of human and mouse adipocytesPradip K Saha, Mark P Hamilton, Kimal Rajapakshe, et al.
The Journal of Clinical Endocrinology and Metabolism|November 25, 2004
Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjectsSangeeta R Kashyap, Linda J Roman, Jennifer Lamont, et al.
Journal of Proteome Research|July 11, 2008
Global relationship between the proteome and transcriptome of human skeletal muscleZhengping Yi, Benjamin P Bowen, Hyonson Hwang, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2010
Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitusMandeep Bajaj, Rais Baig, Swangjit Suraamornkul, et al.
Pageof 6